Rucha Patil: Privilege to Speak at the West Bengal Hemophilia Conclave 2026 on HTA in Hemophilia Therapies
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared on LinkedIn:
”It was a privilege to speak at the West Bengal Hemophilia Conclave 2026, held on 4 July 2026 at Taj Taal Kutir, Kolkata.
I had the opportunity to deliver a lecture on ‘Cost-effectiveness and Health Technology Assessment (HTA) in Hemophilia Therapies: The ICMR Perspective,’ highlighting the role of evidence-based evaluation in improving access to sustainable hemophilia care in India.
My sincere thanks to the Program Director, Prof. (Dr.) Maitreyee Bhattacharyya, for the kind invitation. It was an honour to have the session chaired by the eminent Dr. Prakas Kumar Mandal and Dr. Madhumita Nandi.”
Stay updated with Hemostasis Today.
-
Oct 7, 2026, 09:20Maurizio Bertaina: Optimizing Anticoagulation in Temporary Mechanical Circulatory Support
-
Oct 7, 2026, 08:55Ifeanyichukwu Ifechidere: Cancer, Clotting and Bleeding – The Critical Role of Haemostasis in Oncology
-
Oct 7, 2026, 08:39Pediatric Hematology – Careers in Thrombosis and Blood Disorders – ASH Education
-
Oct 7, 2026, 07:57Edward Lee Carter: When Should Apixaban Become the Default for Acute VTE?
-
Oct 7, 2026, 07:40Annette Bowyer: Exploring New Developments in Thrombin Generation
-
Oct 7, 2026, 07:06Omid Seidizadeh: When Acquired von Willebrand Syndrome Takes Different Paths
-
Oct 7, 2026, 06:49Neeraj Songara: Can a Negative Antibody Screen Be Misleading?
-
Oct 7, 2026, 04:09James P. Crowley: Could the Microbiome Protect Us From Severe EBV Infection?
-
Oct 7, 2026, 03:58Sohanur Rohanman Sohan: Explainable AI for Anemia Prediction Using Machine Learning